27
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Journal
          The Lancet
          The Lancet
          Elsevier BV
          01406736
          December 2017
          December 2017
          : 390
          : 10111
          : 2481-2489
          Article
          10.1016/S0140-6736(17)32346-2
          29029896
          f3e5d3cb-7215-42e2-8fe5-25cec0672b10
          © 2017

          http://www.elsevier.com/tdm/userlicense/1.0/

          History

          Comments

          Comment on this article